This study demonstrates that semi-automated area measurements using public-domain ImageJ software can produce results comparable to the proprietary Heidelberg RegionFinder software. The same pattern of agreement was observed when comparing manual measurements made with ImageJ and those made with the Heidelberg Eye Explorer region overlay tool. A high degree of interobserver agreement was also found within each of the four methods tested. Similar to prior studies,
6,17 we found semi-automated methods to be more accurate and reproducible than manual outlining methods in detecting and monitoring GA progression, particularly when measuring non-homogeneous GA lesions.
Panthier et al.
11 showed that, with increasing GA size, the variability of measurements even with RegionFinder increases. They showed that excellent intraobserver agreement could be achieved for lesions with size up to 15.75 mm
2. With larger lesions, small changes in the semi-automated algorithm may lead to a greater rise in the measured area of GA. In similar fashion, the difference in area measurements when comparing RegionFinder values to each of the manual techniques was strongly correlated with increasing GA lesion size in this study. However, when comparing RegionFinder to semi-automated ImageJ, the difference in area measurements was only moderately correlated with increasing GA lesion size, suggesting that the semi-automated methods may more closely match even as the lesion size increases. Area measurements outside the agreement limits in the Bland–Altman plots were typically related to lesions larger than 17.7 mm
2. The smallest overall differences occurred when comparing Heidelberg RegionFinder with semi-automated ImageJ (0.16 mm
2), followed by comparing manual Heidelberg with manual ImageJ (0.48 mm
2). It was also noteworthy that the mean difference between the two semi-automated methods was only moderately correlated with increasing GA size (
r = 0.60,
P < 0.001), whereas the mean difference between RegionFinder and each of the two manual methods was more strongly correlated with GA lesion size (
r = 0.80,
P < 0.001 for Heidelberg manual;
r = 0.84,
P < 0.001 for ImageJ manual). This further suggests that, as GA size increases, semi-automated ImageJ measurements were more accurate than manual methods.
In this study, we examined the effect of homogeneous lesions versus non-homogeneous lesions on different measurement methods. Previous studies by Holz et al.
8 have defined different patterns of GA based on abnormalities in the junctional zone. They concluded that different FAF patterns have an impact on disease progression and can be considered as prognostic factors. Unlike the previously described junctional patterns, we defined homogeneous lesions as those that are more uniformly hypoautofluorescent compared with non-homogeneous lesions, which were defined as those that had mixed areas of hyper- and hypoautofluorescence within the lesion itself rather than focusing only on the borders. Area measurements using each of the manual methods were in close agreement with RegionFinder for homogeneous lesions but yielded higher values for non-homogeneous lesions. In contrast, the difference in area measurements was not significant when comparing RegionFinder with semi-automated ImageJ for both homogeneous and non-homogeneous lesions. Because both semi-automated methods use a similar detection algorithm that is based on pixel intensity, they are able to measure only the hypoautofluorescent areas even within non-homogeneous lesions compared with the manual methods, which demarcate the boundaries of the lesion and therefore may incorporate some relatively more hyperautofluorescent areas within it. These differences in measurement technique likely explain the discrepancies in area measurements seen between the manual and semi-automated methods, particularly for non-homogeneous lesions, and suggest that the manual methods may not be as reliable for accurate measurement of GA area.
The primary benefits of ImageJ are that it is platform agnostic and can be used to process many popular image file types, including JPEG, Portable Network Graphics (PNG), and Digital Imaging and Communications in Medicine (DICOM). In contrast, platform-based proprietary software (e.g., Heidelberg Eye Explorer, RegionFinder) typically requires a license agreement and the availability of specially formatted image files (e.g., E2E with Heidelberg). In addition, ImageJ is compatible with all popular computer operating systems, such as Windows (Microsoft Corporation, Redmond, WA), macOS (Apple, Inc., Cupertino, CA), and Linux (Linux Foundation, San Francisco, CA). Based on the present study, it appears to be comparable to the proprietary software for measuring the area of GA in FAF images. However, ImageJ could be more efficient if compiling images from multiple sites and/or multiple platforms, as comparatively smaller sized non-proprietary files can be imported into the software.
This study has several limitations. The agreement of different measurement methods in detecting the progression of GA lesions over time was not investigated in this study. Therefore, we could not evaluate how lesion growth might vary with each of those methods. Similarly, we did not explore the prognostic value of homogeneous versus non-homogeneous lesions in predicting the progression of GA. Finally, the sample size was relatively small, and further studies with a larger sample size and also more diverse lesion sizes will be necessary to better elucidate the agreement level of different measurement methods.
In summary, this study demonstrated that manual and semi-automated public domain software tools using ImageJ could be used to measure the area of GA lesions accurately when compared with corresponding methods using proprietary software tools. Given the current multitude of clinical trials focusing on developing new therapies for GA and the possibility that treatments to delay the progression of GA may soon become available, the ability to measure lesion size and monitor progression will become increasingly important. Adapting open-source software to analyze large image databases, such as those being collected by the American Academy of Ophthalmology's Intelligent Research in Sight (IRIS) registry, will be important to understanding disease progression and risk factors across large numbers of patients.